- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Bendamustine USP Related Compound E (HCl)
Bendamustine USP Related Compound E (HCl) | CAS NO: 109882-26-0, also known as Bendamustine USP Related Compound E its chemical | IUPAC name is 4-(5-((2-Chloroethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid hydrochloride. Bendamustine USP Related Compound E (HCl) is potential impurity of Bendamustine. Bendamustine works by interfering with the growth and spread of cancer cells. It's usually administered intravenously, and its side effects can include nausea, fatigue, and a risk of infection due to its effects on bone marrow. Synchemia Research chemical is manufacturer and Supplier of Bendamustine USP Related Compound E (HCl) with comprehensive characterization data that adheres to regulatory guidelines, ensuring its suitability for pharmaceutical QC applications.
Synchemia Research chemical is a leading manufacturer, Supplier and exporter of high-quality Bendamustine USP Related Compound E (HCl) | CAS NO: 109882-26-0, also known as Bendamustine USP Related Compound E (HCl). Multiple Myeloma: Typically used in combination with other medications.Off-label Uses: Sometimes used for other hematological malignancies or solid tumors, depending on the clinical scenario. Buy Reliable and High-Purity Bendamustine USP Related Compound E (HCl), Delivered by Synchemia Research Chemical.
| Product name | Bendamustine USP Related Compound E (HCl) |
| SRC CAT No | SRC-B1421 |
| CAS No | 109882-26-0 |
| Mol.F. | C16H22ClN3O3 : HCl |
| Mol.Wt. | 339.8 : 36.5 g/mol |
| Related CAS No. | 109882-27-1 (Free base) |
| Inv Status | Custom Synthesis |
